IDO is manifested by CAFs and endothelial cells in the tumor stroma of ESCC, which raises the possibility that ESCC cells can avoid immune surveillance by way of CAFs that express IDO. This evidence concerns the gene IDO1 and esophageal squamous cell carcinoma.